Geneology International

Category: Medical CBD

MS lawmakers defy gov’s medical cannabis demands (Newsletter: January 13, 2022)
KY medical cannabis bill filed; MS senator brings hemp to marijuana meeting with gov; CA spends $100M on marijuana cannabis grants for cities

Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.

Your support makes Marijuana Moment possible…

Free to read (but not free to produce)! We’re proud of our newsletter and the reporting we publish at Marijuana Moment, and we’re happy to provide it for free. But it takes a lot of work and resources to make this happen.
- Matt W.: “I pledged because I value the news and information you provide and want to see it continue.”
If you value Marijuana Moment, invest in our success on Patreon so we can expand our coverage and more readers can benefit: https://www.patreon.com/marijuanamoment

/ TOP THINGS TO KNOW

Anti-drug Sen. Charles Grassley (R-IA) has been helping an Iowa church that wants to incorporate the psychedelic brew ayahuasca into its ceremonies—the Iowaska Church of Healing—with legal fights against the Drug Enforcement Administration and the Internal Revenue Service.

A Kentucky Republican representative filed a medical marijuana bill that’s been revised from past versions in an attempt to win support—or at least remove hostile opposition—from legislative leaders so that it can pass this year.

A Mississippi senator brought hemp to a meeting with Gov. Tate Reeves (R) to help assuage the governor’s concerns about medical marijuana possession limits.
- “I took samples to show him what an ounce actually looks like—what 3.5 grams actually looks like.”
California regulators awarded $100 million in funding to help local governments develop the legal marijuana market by processing business licenses.

/ FEDERAL

A federal judge dismissed a Washington State marijuana dispensary’s racial discrimination lawsuit against state and federal officials.

Rep. Dave Joyce (R-OH) criticized Democratic leaders for not advancing cannabis reform legislation.

Rep. Nancy Mace (R-SC) authored a Wall Street Journal letter to the editor about her marijuana legalization bill.

Florida Democratic Senate candidate Allen Ellison tweeted, “Not only should we legalize cannabis across the country, we should tax the sale of it and pay for higher education.”

Kentucky Democratic congressional candidate William Compton tweeted, “Along with the revenue we can generate by legalizing Marijuana, we should not have someone go to jail for Marijuana. In congress, I will fight to legalize Marijuana nationwide.”

/ STATES

Rhode Island’s House speaker said a new marijuana legalization bill should be released in the next 30-45 days.

New Jersey’s Senate president said he doesn’t think home cultivation of marijuana will be legalized “any time soon.”

South Carolina’s Senate majority leader indicated a medical cannabis bill will be considered soon, saying, “I don’t know where the votes will be, but we all agree it’s time to have a debate and move on.” And another senator said he expects the legislation to be one of the first brought up in the new session.

The Wisconsin House State Affairs Committee approved a kratom regulation bill.

Mississippi lawmakers are expected to consider a medical cannabis bill this week. One senator wants pharmacists to be involved in distributing marijuana.

The Virginia legislature’s Cannabis Oversight Commission will meet on Monday.

Kansas House Democrats tweeted, “House Democrats want Kansans like YOU to decide if Kansas should expand Medicaid and legalize marijuana. Contact your #ksleg-legislator TODAY and tell them you want to vote on issues that affect your life and your health.”

A Florida senator filed a marijuana legalization bill and companion tax legislation.

An Indiana representative filed a medical cannabis bill.

A Maryland senator tweeted, “Legalizing marijuana is not about easing access to personal indulgence, it’s about creating equality.”

The Illinois Supreme Court is being asked by a marijuana business to let regulators name the winners of new craft grower licenses.

New York regulators filed proposed cannabinoid hemp rules. Separately, the Department of Agriculture and Markets is seeking certified hemp sampling agents.

The Utah Peace Officer Standards & Training Council voted to make it so cadets applying to be emergency dispatchers will not have to undergo a waiting period if they’ve used marijuana in a place where it’s legal.

Ohio regulators received nine petitions to add new medical cannabis qualifying conditions.

Oregon regulators are conducting a survey on interest in accessing psilocybin services and related issues.

Vermont regulators will consider marijuana issues on Monday.

The Washington State Cannabis Science Task Force will meet on Monday.

—
Marijuana Moment is already tracking more than 900 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.

Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—

/ LOCAL

The Kent, Ohio City Council is moving to place a marijuana decriminalization measure on the November ballot.

Long Beach, California’s mayor tweeted, “In Long Beach we legalized cannabis before the state. We created a regulatory framework and taxed products and production. It’s time to legalize weed across the country.”

Oakland, California officials will discuss loan and grant programs for cannabis equity businesses on Tuesday.

/ INTERNATIONAL

Appointments for first-dose COVID vaccinations in Quebec, Canada spiked after the government announced the shots would be required to enter marijuana dispensaries and liquor stores.

The Australian government is funding clinical trials on psilocybin, CBD, DMT and MDMA-assisted psychotherapy to treat debilitating mental illness.

/ SCIENCE & HEALTH

A study found that “two years after legalization in Canada, the price of dried flower from legal sources decreased, along with a greater percentage of consumers purchasing from legal sources than after one year.”

A study suggested that “MDMA/ecstasy and psilocybin use is associated with lower risk of depression.”

/ ADVOCACY, OPINION & ANALYSIS

The American Medical Association said expanding medical marijuana research will be a topic of discussion at its conference next month.

The Kentucky Democratic Party tweeted, “Democrats are heading to work every day this session committed to fighting for you. Health care, voting rights, universal pre-K, medical marijuana and much more: @GovAndyBeshear, @KYSenateDems and @KYHouseDems are prioritizing the issues Kentuckians care about.”

/ BUSINESS

Columbia Care Inc. is commencing a solicitation of consents from noteholders.

Ayr Wellness sent an update on its stock repurchase program.

Swade Cannabis workers in St Louis, Missouri are seeking to organize a union.

/ CULTURE

Filmmaker Kevin Smith posted about running into his daughter at a marijuana dispensary.

Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
January 14, 2022
CBD for ADHD: Benefits, Considerations, and Uses
Attention deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopment conditions among children, affecting an estimated 11{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of U.S. children. The condition is characterized by having trouble sitting still, an inability to focus, forgetfulness, and disorganization.

Adults can also be diagnosed with ADHD, and about 75{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of kids with ADHD will continue to have ADHD symptoms as adults.

These days, more ADHD patients and parents of children with the condition are curious about whether cannabidiol (CBD), a non-psychoactive extract of the cannabis plant, can be beneficial in managing ADHD symptoms.

CBD has shown promise for treating some health experts, and many experts believe its calming effects could help those with ADHD. However, research is still emerging and caution should be used.

This article will review the potential benefits of CBD for ADHD, the side effects, and how to source the best CBD products.

Vanessa Nunes /iStock/ Getty Images Plus

Using CBD for ADHD Symptoms

The federal prohibition on all cannabis products, including hemp, prior to 2018 has limited research on CBD and ADHD. However, there are some studies about the effects of CBD or cannabis on ADHD symptoms. Here’s what they’ve found:
- A 2020 scientific review gave a grade B, or moderate, recommendation supporting CBD for ADHD treatment.
- A small 2020 study of 112 adult medical cannabis patients with ADHD found that those who took a higher dose of CBD took fewer other ADHD medications.
- A small 2017 study involving 30 individuals found that those who used a CBD nasal spray had a small reduction in hyperactivity, impulsivity, and inattention. However, the improvement was not big enough for researchers to definitely say that CBD spray was more effective than a placebo. The researchers called for further investigation.
The Food and Drug Administration (FDA) has only approved one prescription CBD medication, which is used to treat epilepsy. Research is ongoing for CBD formulate to treat other conditions.

Benefits of CBD

Unlike THC, which acts on cannabinoid receptors in the brain, CBD acts on opioid and glycine receptors. These receptors regulate pain and the neurotransmitter serotonin, which helps us feel good. Unsurprisingly, then, research has shown that CBD can have lots of benefits. These include:
- Reducing inflammation
- Regulating the immune system
- Reducing pain
- Providing antipsychotic effects
- Reducing seizures
- Reducing anxiety
CBD products sometimes claim many additional benefits. However, those listed above have been scientifically proven, while other benefits are often anecdotal or overstated.

Potential Side Effects of CBD

A perk of CBD is that it has very few side effects. CBD does not have any psychoactive effects and it doesn’t have any risk of addiction or abuse. A 2020 scientific review of 22 research studies found no reports of serious adverse side effects.

However, some people who take CBD will experience minor side effects including:
- Drowsiness
- Headache
- Changes to appetite
- Stomach pain or nausea
Things to Consider Before Using CBD

Although many CBD products make claims about treating ADHD, there is no definitive research that shows CDB will help most people with ADHD. It’s best to keep your expectations realistic and remember that even if CBD worked well for someone you know, it will not necessarily improve symptoms for you or your child, and it is not a replacement for treatments recommended by your healthcare team.

You should also consider the legality. It’s important to only use a CBD product that contains less than 0.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} THC, in order to comply with federal law. If you are considering CBD for a child, consult laws in your state and consider using an isolate that contains no THC, which is illegal for people under 21 even in states that have legalized cannabis. Be sure to purchase your CBD products from a reputable dispensary or drugstore so that you know exactly what’s in them.

How to Use CBD

There are no guidelines on how to use CBD for ADHD. CBD oil is widely available and is usually consumed by placing a few drops under the tongue or stirring into coffee or tea. There are also many CBD products available, ranging from supplements to gummies to packaged drinks.

There is also no known dosage for treating ADHD. Many people find they need to experiment to find the right daily dose to manage their symptoms.

If you’re curious about using CBD to treat ADHD, you should talk with your healthcare provider. Although CBD is generally considered safe, it is still a chemical compound that can interact with other supplements or medications.

Remember that CBD oils are mostly unregulated, so there’s also no guarantee that a product is safe, effective, or what it claims to be on its packaging. Your healthcare provider should be able to offer dosage and product recommendations that work with your individualized treatment plan.

Summary

CBD shows some promise for helping to manage ADHD symptoms. However, the research is limited and more research needs to be done to confirm effectiveness, dosage, and safety. CBD is generally considered safe and has few if any side effects. If you are considering trying CBD, talk with your healthcare provider and seek out a quality product for the best results.

A Word From Verywell

The symptoms of ADHD can have a big impact on your life, so it’s normal to look for alternative treatments to supplement your medical treatment plan or manage minor symptoms.

While early research on CBD for ADHD is promising, there are no definitive conclusions yet. If you want to try CBD for ADHD, talk with a trusted healthcare professional. They’ll be able to answer your questions without judgment and craft a treatment plan that is right for you.
Frequently Asked Questions

Is CBD oil safe?

CBD is generally considered very safe. It has no psychoactive properties and is not addictive. Some people experience minor side effects like an upset stomach or drowsiness.

Can you give CBD oil to children?

The FDA has approved one prescription CBD medication for treating epilepsy in children. Outside of that, CBD is considered generally safe, but you should consult your healthcare provider and laws in your state before giving CBD to children.

Is CBD illegal?

CBD is legal at the federal level as long as it is in a form that contains less than 0.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} THC, the other active ingredient in marijuana. The legality of CBD at the state level varies, so be sure to look at laws in your state.
January 13, 2022
Glacial Gold Distilled CBD 200 Oil Available Nationally to Medical Patients Through Mendo

Vancouver, British Columbia–(Newsfile Corp. – January 11, 2022) – Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) (“Nextleaf“, “OILS“, or the “Company“) , a federally regulated manufacturer and distributor of cannabis vapes and oils under its prohibition-era brand, Glacial Gold™, is pleased to announce that Distilled CBD 100 Oil and Distilled CBD 200 Oil are available nationally through its medical cannabis distribution partner, Quebec-based Medicibis (“Mendo“).

Glacial Gold™ Distilled CBD 200 Oil is a first in Canada, with the highest amount of CBD in a single unit (5700 mg), highest potency of CBD available in an ingestible format, and best dollar value per milligram for CBD in Canada.

The Company’s multi-patented ingredient processing technology is the secret behind Glacial Gold™ products. Distilled CBD 200 Oil was developed to meet the needs of the everyday CBD consumer. Glacial Gold™ CBD distilled oils are formulated with organic coconut MCT oil and a standardized dose of CBD.

In British Columbia, Nextleaf is a top 10 supplier of vapes and oils. Glacial Gold™ has multiple products inside the top 20 best selling SKUs within the vape and oils categories.

Figure 1: All Glacial Gold products are available nationally through Mendo Medical

To view an enhanced version of Figure 1, please visit:
https://orders.newsfilecorp.com/files/5347/109650_bbb413370450abaf_001full.jpg

Mendo operates an online portal for medical patients that ships nationwide through www.mendocannabis.ca. All Glacial Gold™ CBD and THC vapes and distilled oils are distributed by Mendo to their patients in Quebec and across Canada.

“We’ve made the process of obtaining a medical cannabis document and becoming a member of Mendo a quick and easy one,” said Jay Schwartz co-founder and COO of Mendo. “Canadians that visit our online platform simply follow a link and schedule a consultation with one of our licensed medical professionals. This is done from the comfort of their home by telephone or video conference. In most cases the applicant’s account is approved within 24 to 36 hours at which point they may begin to place orders for medical cannabis delivered to their home as early as the next business day.” Mr. Schwartz added, “We are delighted to offer all Canadians a carefully curated menu of products with compassion pricing, as well as swift access to receive their medical document at no charge.”

“The team at Mendo are experienced operators with a unique approach in Quebec that has been a major catalyst for the growth of their distribution platform,” said Paul Pedersen co-founder and CEO of Nextleaf. “Nextleaf is pleased for Glacial Gold vapes and distilled oils to be available to medical patients coast to coast through the Mendo platform”.

CBD is increasingly thought of as a potential therapeutic treatment for opioid use disorder. On January 4, 2022, the FDA approved human trials evaluating an investigational drug using CBD to be conducted at UCLA and funded by the U.S. National Institute on Drug Abuse.^[1]

Medical patients including veterans, have made it clear that they need a reliable supply of consistent quality medical cannabis products for those living with PTSD, chronic pain, and other conditions that disproportionately impact veterans. According to a 2019 Veterans Health and Medical Cannabis Study^[2], 96{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of veterans reported they experience a much greater quality of life because of their cannabis consumption.

As part of the Company’s commitment to improving access to medical cannabis, Nextleaf launched an assortment of accessibly priced Glacial Gold™ CBD and THC products for the medical market through Mendo.

Quebec is the third-largest cannabis market in Canada, representing approximately 15{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}^[3] of Canadian cannabis retail sales in the country, and approximately 22{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of the Canadian population^[4]. Canadian spending on medical cannabis totaled $587 million in 2020^[5]. Medical cannabis has become an important component of Canadian healthcare, with $119 million of medical cannabis purchases reimbursed by the Federal Government through Veterans Affairs Canada in 2020^[6].

About Medicibis

Medicibis operates out of its 20,000 sq.ft. facility located 15 minutes from downtown Montreal in St Jean Sur Richelieu. Medicibis also operates an online portal for medical patients that ships nationwide through their website mendocannabis.ca. Mendo’s menu has been carefully curated to offer a variety of products from licensed producers from all over Canada. Mendo is positioned to become one of the leading suppliers of medical cannabis to patients and veterans in the country.

About Nextleaf®

Nextleaf is a federally regulated manufacturer and distributor of cannabis vapes and oils under its award-winning prohibition-era brand, Glacial Gold™. The Company’s multi-patented ingredient processing technology transforms cannabis and hemp biomass into high-purity distillate at an industrial scale. Nextleaf is a low-cost producer of cannabis oils, and supplies THC and CBD ingredients to qualified wholesale partners across Canada. Nextleaf is the first publicly traded company to be issued a U.S. patent for the industrial extraction and purification of cannabinoids. The Company has been issued 17 U.S. patents, and over 90 patents globally, on cannabinoid processing including distillation and acetylation. Nextleaf develops proprietary cannabinoid-based formulations and delivery technology through its Health Canada Research Licence with sensory evaluation of cannabis via human testing. For more information visit www.nextleafsolutions.com and www.Glacial.Gold

Nextleaf Solutions trades as OILS on the Canadian Securities Exchange, OILFF on the OTCQB Market in the United States, and L0MA on the Frankfurt Stock Exchange.

Follow the Company across social platforms: Twitter, LinkedIn, Facebook, and Instagram.

Follow Glacial Gold: Instagram, Twitter, and Facebook.

For more information please contact:
Jason McBride, Corporate Development
604-283-2301 (ext. 219)
[email protected]

On behalf of the Board of Directors of the Company,
Paul Pedersen, CEO

Certain statements contained in this press release constitute “forward-looking statements”. All statements other than statements of historical fact contained in this press release, including, without limitation, those regarding the Company’s ability to capitalize on its IP portfolio, receipt of the Dealer’s Licence within the anticipated timeframe or at all, the activities the Company expects to conduct if the Dealer’s Licence, the ability of the Company to develop and protect intellectual property relating to psychedelics, the expected benefits to the Company if the Dealer’s Licence is received, the Dealer’s License assisting the company in obtaining a unique position for the Company to develop a suite of standardized plant-derived drugs, the Company’s strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words “believe”, “expect”, “aim”, “intend”, “plan”, “continue”, “will”, “may”, “would”, “anticipate”, “estimate”, “forecast”, “predict”, “project”, “seek”, “should” or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company’s expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. Additional factors that could cause actual results, performance or achievements to differ materially include, but are not limited to the risk factors discussed in the Company’s MD&A for the most recent fiscal period. Management provides forward-looking statements because it believes they provide useful information to investors when considering their investment objectives and cautions investors not to place undue reliance on forward-looking information. Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, the Company. These forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update or revise them to reflect subsequent information, events or circumstances or otherwise, except as required by law. The CSE has not reviewed or approved the contents of this press release.

^[1] https://hempindustrydaily.com/fda-signs-off-on-human-cbd-trials-to-treat-opioid-addiction/
^[2] https://www.cannabissciencetech.com/view/the-2019-veterans-health-and-medical-cannabis-study
^[3] Statistics Canada, July 2021 cannabis retail sales
^[4] Statistics Canada
^[5] https://mjbizdaily.com/canadas-legal-cannabis-market-continues-to-erode-illicit-markets-share/
^[6] https://www.veterans.gc.ca/eng/about-vac/research/research-directorate/publications/reports/cmp2018

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/109650

January 12, 2022
Can Cannabis Help With ADHD? Benefits vs. Risks
Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental condition that affects 11{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of school-aged children and an estimated 4.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of adults.

ADHD is characterized by an inability to sit still, trouble focusing, and impulsive behavior. Because cannabis (Cannabis sativa) has been linked to relaxation, many people are curious whether the medicinal herb can be helpful in managing ADHD symptoms.

The research on whether cannabis can provide short-term relief of hyperactivity in people with ADHD is mixed. And researchers are still trying to learn more about cannabis and ADHD. Here’s what you should know about the effects of cannabis on people with ADHD.

Sharon Mccutcheon / EyeEm / Getty Images

How Cannabis Could Help With ADHD Symptoms

To understand how cannabis might provide relief for ADHD symptoms, it’s important to understand the two components of cannabis, which are:
- Tetrahydrocannabinol (THC): THC is a psychoactive component that gives the “high” associated with cannabis. It acts on the areas of the brain that control focus, coordination, and reaction time.
- Cannabidiol (CBD): CBD is a nonpsychoactive component in cannabis and hemp (a type of cannabis plant that contains 0.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} or less THC). It acts on different areas of the brain and can counteract the effects of THC. CBD has been shown to help regulate brain activity.
When you smoke or consume cannabis, you take in both THC and CBD.

Cannabis for ADHD: What Research Says

There isn’t much research on using cannabis for ADHD because federal research on cannabis has been restricted by the drug’s schedule 1 status (drugs not currently accepted for medical use that have a potential for abuse). However, the research that is available gives a mixed answer to the question of can cannabis help with ADHD, including:
- A small 2020 study of 112 adult patients with ADHD who used medical cannabis found that those who took a higher dose of medical cannabis components, like CBD, took fewer other ADHD medications.
- A 2019 medical review of 83 studies found that there was “scant” and “insufficient” evidence on the effectiveness of cannabis to treat mental health conditions, including ADHD.
- A 2021 study of 1,700 students found that those with ADHD self-reported that using cannabis improved their ADHD symptoms and lessened their side effects from their ADHD medication.
- A 2016 study that analyzed online posts mentioning cannabis and ADHD found that 25{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of those posts stated a positive impact of cannabis on ADHD symptoms, as opposed to 8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} that said it was harmful.
More research is needed to determine if cannabis can have benefits for adults with ADHD. However, at this time, most states with medical cannabis programs do not include ADHD as a qualifying condition for getting a license.

Cannabis and Kids

Although ADHD is most often diagnosed in children, cannabis should not be used by most young people. Even states with recreational cannabis laws don’t allow people under 21 years old to purchase or consume cannabis. Medical cannabis programs for children are extremely limited, and ADHD is not a qualifying condition.

Using Cannabis With ADHD Medications

There’s limited research on how cannabis interacts with ADHD medications, such as Adderall (dextroamphetamine–amphetamine). A small 2015 study of adults without ADHD found that when Adderall and marijuana were taken together, they produced unique effects (neither positive nor negative) compared with either medication taken alone.

If you’re on ADHD medications, it’s important that you be upfront and honest with your healthcare provider about your cannabis use. Cannabis use is becoming mainstream and is legal in some places. Your healthcare provider can help you understand the benefits and risks of using cannabis with ADHD medications.

Cannabis Effects by Strain Type

Some people believe that different strains of cannabis produce different effects. Strains are different varieties of the cannabis plant. Common marketing distinguishes between these two strains:
- Sativa is believed to energize.
- Indica is believed to have calming and pain-reducing effects.
However, research shows the differences between strains are not necessarily accurate. The effects of cannabis are dictated by its levels of THC and CBD, with each having different effects on the brain and body. Most Indica strains are thought to have a higher proportion of CBD, which lends them their calming effects.

Most research in favor of cannabis for ADHD shows benefits of CBD, so you may want to choose a cannabis strain with a higher proportion of CBD (such as an Indica product) or try CBD oil (or other CBD-only product) instead of cannabis.

When Does Cannabis Use Become a Substance Use Disorder?

About 30{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of people who use cannabis will develop a substance use disorder. A substance use disorder occurs when substance use begins to interfere with a person’s day-to-day functioning.

Research shows that CBD alone, without THC, is not addictive. So, if you are concerned about developing a substance use disorder, you may want to choose a product with only CBD as opposed to both CBD and THC.

Summary

There’s little research on whether cannabis can help with ADHD. The research that exists is mixed: Some studies have found that cannabis can help with ADHD symptoms, while others conclude there is insufficient evidence to make that conclusion.

In most cases, ADHD doesn’t qualify for state medical cannabis programs, and cannabis should never be used to treat ADHD in people under age 21. It’s best to have an open and honest conversation with your healthcare provider about using cannabis if you have ADHD.

A Word From Verywell

It’s normal to wonder whether cannabis can treat your ADHD symptoms. Unfortunately, there’s no clear answer. Luckily, researchers are continuing to explore the medical potential of cannabis. Hopefully, within a few years, we’ll have a better idea of the impact of marijuana on people with ADHD.
Frequently Asked Questions

Should you talk to your doctor before you stop taking prescribed ADHD medicine?

Yes, you should always talk with your healthcare provider before stopping ADHD medications. Sometimes finding the right medications for ADHD can take time. Rather than stopping your medications, reach out to your medical provider to discuss your concerns.

How much cannabis is too much?

If your cannabis use is interfering with your day-to-day functioning, it’s time to seek help. Remember that even in states with recreational cannabis programs, cannabis is illegal for people who are under the age of 21.

What the best type of cannabis for ADHD?

There’s little research about the effects of different forms of cannabis for people with ADHD. However, CBD seems to show more promise for treating ADHD, compared to cannabis that contains THC and CBD. Talk to your healthcare provider about your specific situation.

Could microdosing cannabis help with ADHD symptoms?

There’s not enough research to conclude whether cannabis helps people with ADHD. This includes microdosing, or the practice of taking ultra low doses of cannabis to help manage symptoms without a high. If you’re interested in microdosing to help control ADHD, talk with your healthcare provider.
January 11, 2022
VA gov won’t overturn legal cannabis, but sales unclear (Newsletter: January 4, 2022)
RI leaders close to legalization deal; Bourbon-selling KY senator worried about medical marijuana; Record IL cannabis sales

Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.

Your support makes Marijuana Moment possible…

Your good deed for the day: donate to an independent publisher like Marijuana Moment and ensure that as many voters as possible have access to the most in-depth cannabis reporting out there.

Support our work at https://www.patreon.com/marijuanamoment

/ TOP THINGS TO KNOW

The federal monopoly on growing cannabis for research has officially ended, with two companies telling Marijuana Moment that they’ve harvested their first Drug Enforcement Administration-approved crops in recent weeks.

Rhode Island’s House speaker and Senate president indicated in opening remarks at the start of the legislative session that they are nearing a deal on how to regulate the marijuana industry in a new legalization bill expected to be filed this month. But Gov. Dan McKee (D) might not be on board with a key detail.

Kentucky’s Senate majority floor leader—who owns a bourbon company called “Kentucky Senator”—said he opposes medical cannabis despite strong support from his constituents.
- “If they don’t like it, they can take it out on me in the next election.”
The Illinois Department of Financial and Professional Regulation reported that marijuana businesses set a sales record in December, closing out a year with nearly $1.4 billion worth of legal cannabis products sold—more than doubling 2020’s total.

/ FEDERAL

Senate Majority Leader Chuck Schumer (D-NY) tweeted, “The War on Drugs has been a war on people—particularly people of color. I’m working to pass our bill to end the federal marijuana prohibition, enact criminal justice reforms, and ensure equity for those impacted by the War on Drugs.”

Pennsylvania Democratic Senate candidate John Fetterman, currently the lieutenant governor, tweeted about a local move to reduce some marijuana charges, saying, “Lebanon 🔴 is one of Pennsylvania’s most conservative counties. I commend the DA for adopting these common sense changes to marijuana charges. Legalization is “inevitable” in PA. Those aren’t my words. They belong to a Republican state Senator.”

Kentucky Democratic Senate candidate Charles Booker tweeted, “There is overwhelming bipartisan support to legalize medical cannabis in Kentucky. The politicians blocking it know that very well.”

Texas Democratic congressional candidate Coy Branscum tweeted, “I support federal efforts to legalize adult use marijuana. This will be a boon for investment in our country and will provide much needed criminal justice reform for our country.”

/ STATES

Mississippi’s lieutenant governor pushed back against Gov. Tate Reeves’s (R) criticism of pending medical cannabis legislation, while the House speaker said it is “not the top issue” for the session. Separately, a senator is proposing a medical marijuana bill that would ban smoking.

Tennessee Democratic gubernatorial candidate Jason Martin tweeted that voters told him it’s a priority to work on “updating Tennessee’s antiquated marijuana laws.”

The Louisiana legislature’s Industrial Hemp Advisory Committee met.

An Indiana representative said he doesn’t think there’s enough support in the legislature to pass marijuana reform.

A Wisconsin senator applauded Gov. Tony Evers (D) for pardoning people with marijuana convictions.

Montana’s Supreme Court has been slow to set up a specialized court to handle marijuana expungements.

Massachusetts’s top marijuana regulator said implementing delivery services can “take a big chunk out of” the illegal market.

Virginia regulators are considering amending rules for marijuana field tests and are accepting comments on proposed changes to rules on medical cannabis product labeling and access to facilities.

Illinois regulators are beginning rulemaking on changes to the medical cannabis program.

The New York Department of Agriculture and Markets tweeted, “We’re proud to announce that our Hemp Program Plan has been approved by @USDA. All growers who were licensed under our former Industrial Hemp Agricultural Research Pilot Program need to reapply under this new program in order to grow hemp this year.”

Colorado regulators gave an update on the marijuana program in the Department of Revenue’s annual report.

Oklahoma regulators sent an update about a switch to new medical cannabis licensing software this month.

The Idaho Global Entrepreneurial Mission reported on hemp projects it is funding.

—
Marijuana Moment is already tracking more than 800 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.

Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—

/ LOCAL

Portland, Oregon officials posted application materials for cannabis business emergency relief funds.

Oakland, California’s Cannabis Regulatory Commission will meet on Thursday.

/ INTERNATIONAL

Philippine President Rodrigo Duterte said he will “never, never apologise for the deaths” in his nation’s bloody “drug war.”

London, England’s mayor clarified that a new arrest diversion plan will only apply to people under 25 and for marijuana only, not other drugs. A spokesperson for UK Prime Minister Boris Johnson reacted by saying that “illegal drugs destroy lives and fuel violence.” And the leader of the Labour Party said he’s “not in favour of changing the drugs laws.”

Quebec, Canada’s government is denying access to marijuana and alcohol retail locations to people who have not received COVID vaccinations.

/ SCIENCE & HEALTH

A study concluded that medical cannabis “use for chronic pain is increasing with cannabis legalization.”

A study of mice suggested that “both cannabinoids and terpenes in oil extracts should be considered as potential therapeutic agents against epileptic seizures and epilepsy.”

/ ADVOCACY, OPINION & ANALYSIS

The Kentucky Democratic Party tweeted, “Nine out of 10 Kentuckians support legalizing medical marijuana. Republicans in Frankfort aren’t representing Kentucky’s interests — just their own.”

The Indiana Democratic Party tweeted, “A state that Donald Trump won by 16 points [Montana] made recreational cannabis legal. The @indgop’s opposition to marijuana is more out of touch with most of the larger @GOP. Their partisanship is harming Indiana’s economic potential.”

The Association for Cannabis Health and Medicine will host a summit on cannabis in sports on January 22.

/ BUSINESS

MJBiz was acquired by Emerald Holding, Inc.

The Scotts Miracle-Gro Company acquired Luxx Lighting and True Liberty Bags.

Trulieve Cannabis Corp. won a dismissal of a lawsuit that accused the company of misleading investors about the quality of its cultivation facilities.

The Honeybee Collective raised a $107,000 funding round.

/ CULTURE

David Crosby gave a reporter tips about how to roll a joint and spoke about his forthcoming cannabis brand.

Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
January 10, 2022
Medical cannabis holds promise to help people with inflammatory skin conditions

Persons with pores and skin situations are open to hoping professional medical hashish items as probable treatments in accordance to a analyze from the George Washington University University of Medication and Health Sciences and College of Maryland.

People today with skin problems are open up to hoping clinical cannabis products and solutions as probable solutions, in accordance to a review from The George Washington College School of Medication and Wellbeing Sciences and the College of Maryland.

The study, explained to be the biggest of its kind involving 504 respondents, uncovered that 88.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} help the use of medical hashish for dermatologic health conditions and several currently are carrying out so even with no advice from a dermatologist.

Items out there in excess of-the-counter are hemp-derived and made up of CBD or cannabidiol they have extremely little or no THC. Each THC and CBD are naturally happening in hashish vegetation but CBD isn’t brain altering and won’t result in a large like THC.

Practically 18{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of all those surveyed explained they use around-the-counter health care cannabis merchandise, or MCPs, in the variety of creams or oil-based mostly products and solutions to take care of ailments, these types of as acne breakouts, rosacea, atopic dermatitis and psoriasis.

“Given that we know that consumers are currently employing hashish-dependent products with no a doctor’s recommendation, it is of the utmost worth that items out there above-the-counter have a sure amount of high-quality assurance,” stated Dr. Adam Friedman, professor and chair of dermatology at The George Washington College School of Drugs and Overall health Sciences in D.C.

Friedman endorses individuals check a product’s business web site or request the statement of top quality assurance, which goes in excess of all the things from basic safety to probably even include things like facts about efficacy. He explained not getting capable to get a assertion of quality assurance ought to be a obvious indication not to use the merchandise.

“The globe of health-related hashish is even now in its infancy, significantly of which is mainly because of all the restricted regulation and the unlawful designation of anything at all from the hashish plant,” Friedman said.

He thinks that the potential should really be dazzling for MCPs since of what science is discovering about the human endocannabinoid program. It can be manipulated with cannabis to have incredible impact on inflammation and mobile turnover.

“The endocannabinoid program regulates a lot of different biological procedures. It contains endocannabinoids, indicating cannabinoids, like discovered in the hashish plant that our bodies make that then bind to cannabis receptors to do a full range of things from sending indicators of agony and itch to regulating inflammation and even how cells make on their own,” he explained.

“The long run is tremendously shiny for the translation of hashish to the bedside, in pretty much every self-control in drugs, the science is there. We now require the clinical study to verify what products will work on what,” Friedman claimed.

Like WTOP on Facebook and abide by WTOP on Twitter and Instagram to have interaction in discussion about this post and many others.

Get breaking news and day-to-day headlines sent to your email inbox by signing up listed here.

© 2022 WTOP. All Rights Reserved. This website is not supposed for people positioned inside the European Economic Area.

January 9, 2022